| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f99851c02f7e8359ac847fbc3180f7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c26e99243f8f6187be782f18b701fd13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 |
| filingDate |
2007-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45fb6580dae2da1513b1623d45692174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ef8ce9f976f372707f95b757424668a |
| publicationDate |
2008-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008118433-A1 |
| titleOfInvention |
Preparation and method utilizing radiolabeled chlorotoxin |
| abstract |
The inventors propose to label a chlorotoxin with I-123 or I-124 for a diagnostic agent, and with I-124 or I-131 for a therapeutic agent to reduce tumors and then to use a process they previously invented to stabilize the radiopharmaceutical. The inventors propose to reconstitute the preferred agents and administer them cyclically to diagnose and treat tumors. The inventors also propose a TETA or DOTA link to a metal radioisotope. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109310193-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11160352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11173292-B2 |
| priorityDate |
2004-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |